Surface Oncology is an immuno-oncology company focused on using its knowledge of the biological pathways crucial to the immunosuppressive tumor microenvironment (TME) for the development of cancer therapies. NZV930 and SRF617 are antibodies inhibiting cluster of differentiation (CD) 73 and CD39, respectively, and illustrate how Co.'s knowledge of TME biology can be utilized across programs. SRF388 is an antibody targeting interleukin 27, an immunosuppressive cytokine, or protein that is overexpressed in certain cancers, including hepatocellular, lung and renal cell carcinoma. GSK4381562 is an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells. We show 23 historical shares outstanding datapoints in our SURF shares outstanding history coverage, used to compute SURF market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SURF market cap history over the course of time is important for investors
interested in comparing SURF's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SURF versus a peer is one thing; comparing
SURF market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SURF can fluctuate over the course of history.
With this page we aim to empower investors researching SURF by allowing them to research the SURF market cap history. |
Free SURF Email Alerts:
Video: The Importance of Market Cap
